Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.

Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.

Item
http://www.wikidata.org/entity/Q36295178
Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure.Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate.Hydralazine induces stress resistance and extends C. elegans lifespan by activating the NRF2/SKN-1 signalling pathway.Tannins Enriched Fraction of Emblica officinalis Fruits Alleviates High-Salt and Cholesterol Diet-Induced Cognitive Impairment in Rats via Nrf2-ARE Pathway.Neuroprotective Effects of Four Phenylethanoid Glycosides on H₂O₂-Induced Apoptosis on PC12 Cells via the Nrf2/ARE Pathway.Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease.Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models
P2860

Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.

Item
http://www.wikidata.org/entity/Q36295178
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
@ast
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
@en
type
label
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
@ast
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
@en
prefLabel
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
@ast
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PGEN.1006593
P433
P478
P50
P577
P698
P921
P932